E44-32617-27216
5 vaccinations
1 coded response
39 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-05-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
23B-32723-83991
Child or adolescent in my care · Female · 2022-06-26
RM6-20113-27010
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-04-01
Dose 1 — Moderna
-
2021-04-30
Dose 2 — Moderna
-
2021-05-02
Registered in v-safe
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Fatigue, Headache, Myalgia — Feeling: GoodFree text: Beginning 10 hours after my second dose injection, I had fairly severe headache, muscle ache, joint pain, and fatigue. The symptoms started becoming less severe after about 18 hours (28 hours after injection), and were mild by 48 hours after injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-12
- 2021-07-30
- 2021-10-29
-
2021-11-01
Dose 3 — Moderna
- 2021-11-01
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2022-01-31
- 2022-05-02
-
2022-09-06
Dose 4 — Moderna
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
-
2022-11-14
Dose 5 — Moderna
- 2022-12-06
- 2022-12-06
- 2022-12-12
- 2022-12-19
- 2022-12-26
- 2023-02-13
- 2023-05-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Moderna | |
| 2 | 2021-04-30 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-09-06 | Moderna | No |
| 5 | 2022-11-14 | Moderna | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Beginning 10 hours after my second dose injection, I had fairly severe headache, muscle ache, joint pain, and fatigue. The symptoms started becoming less severe after about 18 hours (28 hours after injection), and were mild by 48 hours after injection.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release